Source document: https://docs-lawep.s3.us-east-2.amazonaws.com/1696589006331.pdf (Vanuatu)
[BCC1]Any?

[BCC1]Any?
Triple elimination of mother-to-child transmission of HIV, syphilis and hepatitis B in the Pacific Islands, 2009-2019 Author: van Gemert, C1,2,3 Affiliations: (1) Vanuatu Health Program, (2) University of Melbourne (3) Burnet Institute, Australia Background Methods • Without intervention, HIV, hepatitis B virus and syphilis can be transmitted from mother-to-child during pregnancy, birth and breastfeeding and these can cause adverse pregnancy and longer-term outcomes1-4 • The 22 Pacific Island countries and territories (PICTs) have among the highest global prevalence of syphilis and hepatitis B. Mother-to-child transmission remains a concern.
• Global and regional elimination impact targets have been set to eliminate mother-to-child transmission (EMTCT) by 2030 and programme targets have been set to indicate progress towards meeting the impact targets5 • The purpose of this study was to assess the availability of data to inform EMTCT programme targets.

• • A systematic review was conducted to extract and collate program target data for 2000-2019 from peer reviewed literature, online WHO and UNICEF data repositories and grey literature.
Program targets were ≥95 for the following:  Antenatal care coverage (at least one visit)  Births attended by skilled health personnel  Proportion of women who were screened for HIV during pregnancy  Proportion of women who were screened for syphilis during pregnancy  Proportion of women who were screened for hepatitis B during pregnancy  Treatment coverage during pregnancy - HIV  Treatment coverage during pregnancy - syphilis  Hepatitis B vaccine birth-dose coverage  Hepatitis B vaccine third-dose coverage Results • Peer reviewed literature: 296 unique reports were screened and 16 were included • Online data repository: Data for 10 indicators from 14 countries were available • Grey literature: Reports were available for three indicators and seven countries.
Peer reviewed literature was of good quality • • Availability of program target data varied between countries • No country reported data for all programme targets; Marshall Islands, Papua New Guinea and Solomon Islands and Tuvalu reported the most programme target data and the most indicators that were achieving or close to the programme targets There was no data identified for Wallis and Futuna or Pitcairn Islands and limited data identified for American Samoa, French Polynesia, Northern Mariana Islands and Tokelau • Conclusions and Recommendations • PICTs do not currently collect enough data to report on the coverage of the various process indicators included in the Triple Elimination Framework • Major gaps are hepatitis B screening in pregnancy and HIV treatment coverage in pregnancy • Whilst some countries appear to have made progress towards elimination impact targets, given the lack of programme target data, no PICT would be ready to apply for validation of elimination • There are major data gaps and major investment is needed to support PICT to collect and report EMTCT data References 1.
Kurewa EN, Gumbo FZ, Munjoma MW, Mapingure MP, Chirenje MZ, Rusakaniko S, et al.

Effect of maternal HIV status on infant mortality: evidence from a 9-month follow-up of mothers and their infants in Zimbabwe.

J Perinatol.

2010;30(2):88-92.

2.

World Health Organization.

Hepatitis B vaccines: WHO position paper.

Weekly epidemiological record.

2009;40(84):405-20.

3.

Chaudhuri AK, Follett EA, Burrell CJ.

Anti-e and vertical transmission of hepatitis B surface antigen.

Br Med J.
Br Med J.

1977;2(6099):1416-7 4.

De Santis M, De Luca C, Mappa I, Spagnuolo T, Licameli A, Straface G, et al.

Syphilis Infection during Pregnancy: Fetal Risks and Clinical Management %J Infectious Diseases in Obstetrics and Gynecology.

2012;2012:5.

5.

World Health Organization Regional Office for the Western Pacific.

Regional Framework for the Triple Elimination of Mother-to- Child Transmission of HIV, Hepatitis B and Syphilis in Asia and the Pacific, 2018–2030.

Manilla; 2018.
% antenatal care coverage (at least one visit) % births attended by skilled health personnel% women screened for HIV during pregnancy% women screened for syphilis during pregnancy% women screened for hepatitis B during pregnancy% treatment coverage during pregnancy - HIV% treatment coverage during pregnancy - syphilis% hepatitis B vaccine birth-dose coverage% hepatitis B vaccine third-dose coverageTarget: ≥95%≥95%≥95%≥95%≥95%≥95%≥95%≥95%≥95%American Samoa96.782Cook Islands1001001009999Federated States of Micronesia8010094.5707580Fiji10099.7100959099French Polynesia9198Guam68.99496.710083Kiribati88.498.3421008990Marshall Islands81.290.110096.61009482Nauru94.597.461.861.89987New Caledonia88.69893Niue1001005499Northern Mariana Islands9571Palau90.31001009998Papua New Guinea78.8536224.941772556Pitcairn IslandsSamoa93.382.598.71006774Solomon Islands88.586.2154.91006799Tokelau88100Tonga9995.58292508881Tuvalu97.493.11001001009996Vanuatu75.689.482.11008085Wallis and FutunaLEGEND:≥80% (close to or achieving programme target)≥60% - <80%<60%